Selected research
Industry Growth & Trends
Global Megestrol Industry Growth and Trends Forecast to 2032
Market perspective
The global Megestrol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Megestrol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Megestrol is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Megestrol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Megestrol include Abbott, Takeda, Sandoz, Novartis, Mylan, Pfizer, GSK, Mayne Pharma and Guccess, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Megestrol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Megestrol market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Megestrol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Megestrol.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Megestrol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Megestrol Market by Company
Abbott
Takeda
Sandoz
Novartis
Mylan
Pfizer
GSK
Mayne Pharma
Guccess
Bristol Myers Squibb
Abnova
Megestrol Segment by Type
Oral Suspension
Tablet
Injection
Others
Megestrol Segment by Application
Hospital
Clinic
Others
Megestrol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Megestrol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Megestrol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Megestrol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Megestrol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Megestrol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Suspension
- Tablet
- Injection
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Abbott
- Takeda
- Sandoz
- Novartis
- Mylan
- Pfizer
- GSK
- Mayne Pharma
- Guccess
- Bristol Myers Squibb
- Abnova
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Megestrol Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Megestrol Sales Estimates and Forecasts (2021-2032)
- 1.3 Megestrol Market by Type
- 1.3.1 Oral Suspension
- 1.3.2 Tablet
- 1.3.3 Injection
- 1.3.4 Others
- 1.4 Global Megestrol Market Size by Type
- 1.4.1 Global Megestrol Market Size Overview by Type (2021-2032)
- 1.4.2 Global Megestrol Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Megestrol Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Megestrol Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Megestrol Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Megestrol Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Megestrol Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Megestrol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Megestrol Industry Trends
- 2.2 Megestrol Industry Drivers
- 2.3 Megestrol Industry Opportunities and Challenges
- 2.4 Megestrol Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Megestrol Revenue (2021-2026)
- 3.2 Global Top Players by Megestrol Sales (2021-2026)
- 3.3 Global Top Players by Megestrol Price (2021-2026)
- 3.4 Global Megestrol Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Megestrol Major Company Production Sites & Headquarters
- 3.6 Global Megestrol Company, Product Type & Application
- 3.7 Global Megestrol Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Megestrol Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Megestrol Players Market Share by Revenue in 2025
- 3.8.3 2025 Megestrol Tier 1, Tier 2, and Tier 3
4 Megestrol Regional Status and Outlook
- 4.1 Global Megestrol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Megestrol Historic Market Size by Region
- 4.2.1 Global Megestrol Sales in Volume by Region (2021-2026)
- 4.2.2 Global Megestrol Sales in Value by Region (2021-2026)
- 4.2.3 Global Megestrol Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Megestrol Forecasted Market Size by Region
- 4.3.1 Global Megestrol Sales in Volume by Region (2027-2032)
- 4.3.2 Global Megestrol Sales in Value by Region (2027-2032)
- 4.3.3 Global Megestrol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Megestrol by Application
- 5.1 Megestrol Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Megestrol Market Size by Application
- 5.2.1 Global Megestrol Market Size Overview by Application (2021-2032)
- 5.2.2 Global Megestrol Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Megestrol Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Megestrol Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Megestrol Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Megestrol Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Megestrol Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Megestrol Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Megestrol Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Abbott Megestrol Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 Takeda
- 6.2.1 Takeda Company Information
- 6.2.2 Takeda Business Overview
- 6.2.3 Takeda Megestrol Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Takeda Megestrol Product Portfolio
- 6.2.5 Takeda Recent Developments
- 6.3 Sandoz
- 6.3.1 Sandoz Company Information
- 6.3.2 Sandoz Business Overview
- 6.3.3 Sandoz Megestrol Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sandoz Megestrol Product Portfolio
- 6.3.5 Sandoz Recent Developments
- 6.4 Novartis
- 6.4.1 Novartis Company Information
- 6.4.2 Novartis Business Overview
- 6.4.3 Novartis Megestrol Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Novartis Megestrol Product Portfolio
- 6.4.5 Novartis Recent Developments
- 6.5 Mylan
- 6.5.1 Mylan Company Information
- 6.5.2 Mylan Business Overview
- 6.5.3 Mylan Megestrol Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Mylan Megestrol Product Portfolio
- 6.5.5 Mylan Recent Developments
- 6.6 Pfizer
- 6.6.1 Pfizer Company Information
- 6.6.2 Pfizer Business Overview
- 6.6.3 Pfizer Megestrol Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Pfizer Megestrol Product Portfolio
- 6.6.5 Pfizer Recent Developments
- 6.7 GSK
- 6.7.1 GSK Company Information
- 6.7.2 GSK Business Overview
- 6.7.3 GSK Megestrol Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 GSK Megestrol Product Portfolio
- 6.7.5 GSK Recent Developments
- 6.8 Mayne Pharma
- 6.8.1 Mayne Pharma Company Information
- 6.8.2 Mayne Pharma Business Overview
- 6.8.3 Mayne Pharma Megestrol Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Mayne Pharma Megestrol Product Portfolio
- 6.8.5 Mayne Pharma Recent Developments
- 6.9 Guccess
- 6.9.1 Guccess Company Information
- 6.9.2 Guccess Business Overview
- 6.9.3 Guccess Megestrol Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Guccess Megestrol Product Portfolio
- 6.9.5 Guccess Recent Developments
- 6.10 Bristol Myers Squibb
- 6.10.1 Bristol Myers Squibb Company Information
- 6.10.2 Bristol Myers Squibb Business Overview
- 6.10.3 Bristol Myers Squibb Megestrol Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Bristol Myers Squibb Megestrol Product Portfolio
- 6.10.5 Bristol Myers Squibb Recent Developments
- 6.11 Abnova
- 6.11.1 Abnova Company Information
- 6.11.2 Abnova Business Overview
- 6.11.3 Abnova Megestrol Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Abnova Megestrol Product Portfolio
- 6.11.5 Abnova Recent Developments
7 North America by Country
- 7.1 North America Megestrol Sales by Country
- 7.1.1 North America Megestrol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Megestrol Sales by Country (2021-2026)
- 7.1.3 North America Megestrol Sales Forecast by Country (2027-2032)
- 7.2 North America Megestrol Market Size by Country
- 7.2.1 North America Megestrol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Megestrol Market Size by Country (2021-2026)
- 7.2.3 North America Megestrol Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Megestrol Sales by Country
- 8.1.1 Europe Megestrol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Megestrol Sales by Country (2021-2026)
- 8.1.3 Europe Megestrol Sales Forecast by Country (2027-2032)
- 8.2 Europe Megestrol Market Size by Country
- 8.2.1 Europe Megestrol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Megestrol Market Size by Country (2021-2026)
- 8.2.3 Europe Megestrol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Megestrol Sales by Country
- 9.1.1 Asia-Pacific Megestrol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Megestrol Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Megestrol Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Megestrol Market Size by Country
- 9.2.1 Asia-Pacific Megestrol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Megestrol Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Megestrol Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Megestrol Sales by Country
- 10.1.1 South America Megestrol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Megestrol Sales by Country (2021-2026)
- 10.1.3 South America Megestrol Sales Forecast by Country (2027-2032)
- 10.2 South America Megestrol Market Size by Country
- 10.2.1 South America Megestrol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Megestrol Market Size by Country (2021-2026)
- 10.2.3 South America Megestrol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Megestrol Sales by Country
- 11.1.1 Middle East and Africa Megestrol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Megestrol Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Megestrol Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Megestrol Market Size by Country
- 11.2.1 Middle East and Africa Megestrol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Megestrol Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Megestrol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Megestrol Value Chain Analysis
- 12.1.1 Megestrol Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Megestrol Production Mode & Process
- 12.2 Megestrol Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Megestrol Distributors
- 12.2.3 Megestrol Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst